1.Sepkowitz KA. Occupationally acquired infections in health care workers. Part I. Ann Intern Med 1996;125:826–834.
2.Sepkowitz KA. Occupationally acquired infections in health care workers Part II. Ann Intern Med 1996;125:917–928.
3.Garner JS, Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996;17:53–80.
4.Williams WW. CDC guideline for infection control in hospital personnel. Infect Control 1983;4(suppl):326–349.
5.Centers for Disease Control and Prevention, National Institutes for Health. Biosafety in Microbiological and Biomedical Laboratories. 3rd ed. Atlanta, GA: US Department of Health and Human Services, Public Health Service; 1993.
6.National Committee for Clinical Laboratory Standards. Protection of laboratory workers from infectious disease transmitted by blood, body fluids, and tissue: tentative guideline. NCCLS Document M29- T2. Villanova, PA: NCCLS; 1991;11(14):1–214.
7.Heseltine PNR, Ripper M, Wohlford P. Nosocomial rubella—consequences of an outbreak and efficacy of a mandatory immunization program. Infect Control 1985;6:371–374.
8.Centers for Disease Control. Update on adult immunization: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991;40(RR-12):1–94.
9.Centers for Disease Control and Prevention. Immunization of healthcare workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR 1997;46(RR-18):1–42.
10.Centers for Disease Control. Protection against viral hepatitis: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1990;39(RR-2):1–27.
11.Centers for Disease Control. Measles prevention: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1989;38(S-9):1–18.
12.Centers for Disease Control. Mumps prevention: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1989;38:388–392, 397–400.
13.Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immunizations Practices (ACIP). MMWR 1996;45(RR-11):1–36.
14.Centers for Disease Control. Rubella prevention: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1990;39(RR-15):1–18.
15.Centers for Disease Control and Prevention. Control and prevention of meningococcal disease and control and prevention of serogroup C meningococcal disease: evaluation and management of suspected outbreaks: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997;46(RR-5):1–21.
16.Centers for Disease Control and Prevention. Update: vaccine side effects, adverse reactions, contraindications, and precautions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996;45(RR-12):1–35.
17.Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997;46(RR-9):1–25.
18.Centers for Disease Control. Vaccinia (smallpox) vaccine: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991;40(RR-14):1–10.
19.Centers for Disease Control. Diphtheria, tetanus, pertussis: recommendations for vaccine use and other preventive measures—recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991;40(RR-10):1–28.
20.Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997;46(RR-8):1–24.
21.Centers for Disease Control and Prevention. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997;46(RR-3):1–25.
22.Centers for Disease Control. Rabies prevention—United States, 1991: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991;40(RR-3):1–19.
23.Centers for Disease Control and Prevention. Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompe- tence. MMWR 1993;42(RR-4):1–18.
24.American College of Physicians Task Force on Adult Immunization and Infectious Diseases Society of America. Guide for Adult Immunization. 3rd ed. Philadelphia, PA: American College of Physicians; 1994.
25.Herwaldt LA, Pottinger JM, Carter CD, Barr BA, Miller ED. Exposure workups. Infect Control Hosp Epidemiol 1997;18:850–871.
26.US Department of Labor, Occupational Health and Safety Administration. Record keeping guidelines for occupational injuries and illnesses: the occupational safety and health act of 1970 and 29 CFR 1904. OMB no. 120-0029. Washington, DC: US Department of Labor; 1986.
27.US Department of Labor, Occupational Safety and Health Administration. Occupational exposure to bloodborne pathogens; final rule. CFR part 1910.1030. Federal Register 1991;56:64004–64182.
28.US Department of Labor, Occupational Health and Safety Administration. Criteria for recording on OSHA form 200. OSHA instruction 1993; standard 1904. Washington, DC: US Department of Labor; 1993.
29.US Department of Labor, Occupational Safety and Health Administration. Enforcement procedures and scheduling for occupational exposure to tuberculosis. OSHA instruction 1996; CPL 2.106. Washington, DC: US Department of Labor; 1996.
30.Centers for Disease Control. Recommendations for prevention of HIV transmission in health-care settings. MMWR 1987;36(2S):1S–18S.
31.Centers for Disease Control. Update: Universal Precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. MMWR 1988;37:377-382, 387–388.
32.Centers for Disease Control. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers. MMWR 1989;38(S-6):1–36.
33.Centers for Disease Control. Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use. MMWR 1990;39(RR-1):1–14.
34.Centers for Disease Control. Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR 1991;40(RR-4):1–17.
35.Centers for Disease Control and Prevention. Recommended infection-control practices for dentistry, 1993. MMWR 1993;41(RR-8):1–12.
36.Centers for Disease Control and Prevention. Human immunodeficiency virus transmission in household settings—United States. MMWR 1994;43:347, 353–356.
37.Centers for Disease Control and Prevention. Recommendations for follow-up of health-care workers after occupational exposure to hepatitis C virus. MMWR 1997;46:603–606.
38.Centers for Disease Control and Prevention, National Institutes for Health. Agent summary statement: retroviruses, including human and simian immunodeficiency viruses. In: Richmond JY, McKinney RW, eds. Biosafety in Microbiological and Biomedical Laboratories. 3rd ed. Washington, DC: US Government Printing Office; 1993:116–121.
39.Centers for Disease Control. Occupationally acquired human immunodeficiency virus infections in laboratories producing virus concentrates in large quantities: conclusions and recommendations of an expert team convened by the director of the National Institutes of Health (NIH). MMWR 1988;37(S-4):19–22.
40.Centers for Disease Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991;40(RR-13):1–25.
41.Bolyard EA, Bell DM. Universal Precautions in the health care setting. In: Devita VT, Hellman S, Rosenberg SA, eds. AIDS: Etiology, Diagnosis, Treatment and Prevention. 4th ed. Philadelphia, PA: Lippincott-Raven; 1997:655–664.
42.Benson JS. FDA safety alert: needlestick and other risks from hypodermic needles on secondary IV administration sets—piggyback and intermittent IV. Rockville, MD: US Department of Health and Human Services, Food and Drug Administration; 04 16, 1992.
43.Rhodes RS, Bell DM, eds. Prevention of transmission of bloodborne pathogens. Surg Clin North Am 1995;75:1047–1217.
44.Short LJ, Benson DR. Special considerations for surgeons. In: Devita VT, Hellman H, Rosenberg SA, eds. AIDS: Etiology, Diagnosis, Treatment, and Prevention. Philadelphia, PA: Lippincott-Raven; 1997: 665–673.
45.Cardo DM, Culver DH, Ciesielski C, Srivastava PU, Marcus R, Abite-boul D, et al.A case-control study of HIV seroconversion in health care workers after percutaneous exposure. N Engl J Med 1997;337:1485–1490.
46.Centers for Disease Control and Prevention. Evaluation of safety devices for preventing percutaneous injuries among health-care workers during phlebotomy procedures—Minneapolis-St. Paul, New York City, and San Francisco, 1993-1995. MMWR 1997;46:21–25.
47.Centers for Disease Control and Prevention. Evaluation of blunt suture needles in preventing percutaneous injuries among healthcare workers during gynecologic surgical procedures—New York City, March 1993-June 1994. MMWR 1997;46:25–29.
48.Centers for Disease Control. Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures. MMWR 1991;40(RR-8):1–9.
49.Thomas DL, Factor SH, Kelen GD, Washington AS, Taylor E Jr, Quinn TC. Viral hepatitis in health care personnel at the Johns Hopkins Hospital: the seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection. Arch Intern Med 1993;153:1705–1712.
50.Dienstag JL, Ryan DM. Occupational exposure to hepatitis B virus in hospital personnel: infection or immunization? Am J Epidemiol 1982;115:26–39.
51.Shapiro CN, Tokars JI, Chamberland ME, American Academy of Orthopaedic Surgeons Serosurvey Study Committee. Use of the hepatitis B vaccine and infection with hepatitis B and C among orthopaedic surgeons. J Bone Joint Surg 1996;78A:1791–1800.
52.Gibas A, Blewett DR, Schoenfield DA, Dienstag JL. Prevalence and incidence of viral hepatitis in health workers in the prehepatitis B vaccination era. Am J Epidemiol 1992;136:603–610.
53.Hadler SC, Doto IL, Maynard JE, Smith J, Clark B, Mosley J, et al.Occupational risk of hepatitis B infection in hospital workers. Infect Control 1985;6:24–31.
54.Shapiro CN. Occupational risk of infection with hepatitis B and hepatitis C virus. Surg Clin North Am 1995;75:1047–1056.
55.Moyer LA, Alter MJ, Favero MS. Hemodialysis-associated hepatitis B: revised recommendations for serologic screening. Semin Dialysis 1990;3:201–204.
56.Hadler SC, Margolis HS. Hepatitis B immunization: vaccine types, efficacy, and indications for immunization. Curr Clin Top Infect Dis 1992;12:282–308.
57.Wainwright RB, Bulkow LR, Parkinson AJ, Zanis C, McMahon BJ. Protection provided by hepatitis B vaccine in a Yupik Eskimo population—results of a 10-year study. J Infect Dis 1997;175:674–677.
58.Alter MJ, Coleman PJ, Alexander WJ, Kramer E, Miller JK, Mandel E, et al.Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA 1989;262:1201–1205.
59.Alter MJ. The detection, transmission, and outcome of hepatitis C virus infection. Infect Agents Dis 1993;2:155–166.
60.Alter MJ, Gerety RJ, Smallwood LA, Sampliner RE, Tabor E, Deinhardt F, et al.Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban United States population. J Infect Dis 1982;145:886–893.
61.Polish LB, Tong MJ, Co RL, Coleman PJ, Alter MJ. Risk factors for hepatitis C virus infection among health care personnel in a community hospital. Am J Infect Control 1993;21:196–200.
62.Cooper BW, Krusell A, Tilton RC, Goodwin R, Levitz RE. Seropreva-lence of antibodies to hepatitis C virus in high-risk hospital personnel. Infect Control Hosp Epidemiol 1992;13:82–85.
63.Panlilio AL, Shapiro CN, Schable CA, Mendelson MH, Montecalvo MA, Kunches LM, et al.Serosurvey of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among hospi tal-based surgeons. J Am Coll Surg 1995;180:16–24.
64.Nishimura Y, Yamaguchi K, Williams NP, Takatsuki K. Antibodies to hepatitis C virus in Japanese blood donors and in hospital personnel. Transfusion 1990;30:667–668.
65.Herbert AM, Walker DM, Kavies KJ, Bagg J. Occupationally acquired hepatitis C virus infection. Lancet 1992;339:305. Letter.
66.Tsude K, Fujiyama S, Sato S, Kawano S, Taura Y, Yoshida K, et al.Two cases of accidental transmission of hepatitis C to medical staff. Hepatogastroenterology 1992;39:73–75.
67.Zuckerman J, Clewley G, Griffiths P, Cockcroft A. Prevalence of hepatitis C antibodies in clinical health-care workers. Lancet 1994;343:1618–1620.
68.Petrosilla N, Puro V, Ipolito G, and the Italian Study Group on blood-borne Occupational Risk in Dialysis. Prevalence of hepatitis C antibodies in health-care workers. Lancet 1994;344:339–340.
69.Lanphear BP, Linneman CC, Cannon CG, DeRonde MM, Pendy L, Kerley LM. Hepatitis C virus infection in health care workers: risk of exposure and infection. Infect Control Hosp Epidemiol 1994;15:745–750.
70.Mitsui T, Iwano K, Masuko K, Yamazak C, Okamoto H, Tsuda F, et al.Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology 1992;16:1109–1114.
71.Knodell RG, Conrad ME, Ginsberg AL, Bell CJ. Efficacy of prophylactic gamma-globulin in preventing non-A, non-B post-transfusion hepatitis. Lancet 1976;1:557–561.
72.Seeff LB, Zimmerman HJ, Wright EC, Finkelstein JD, Garcia-Pont P, Greenlee HB, et al.A randomized, double blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis: a Veterans Administration cooperative study. Gastroenterology 1977;72:111–121.
73.Sanchez-Quijano A, Pineda JA, lissen E, Leal M, Diaz-Torres MA, Garcia DePesquera F, et al.Prevention of post-transfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients. Lancet 1988;1:1245–1249.
74.Krawczynski K, Alter MJ, Govindarajan S, Tankersley DL, Lambert S, Meeks E, et al.Studies on protective efficacy of hepatitis C immunoglobulins (HCIG) in experimental hepatitis C virus infection. Hepatology 1993;18:110A. Abstract.
75.Tokars JI, Marcus R, Culver DH, Schable CA, McKibben PS, Bandea CL, et al.Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. Ann Intern Med 1993;118:913–919.
76.Henderson D. HIV-1 in the health care setting. In: Mandel G, Bennett J, Dolan R, eds. Principles and Practices of Infectious Diseases. 4th ed. New York, NY: Churchill Livingstone; 1995:2632–2656.
77.Puro V, Ippolito G, Guzzanti E, Serafin I, Pagano G, Suter F, et al.Zidovudine prophylaxis after accidental exposure to HIV: the Italian experience. AIDS 1992;6:963–969.
78.Chamberland ME, Ciesielski CA, Howard RJ, Fry DE, Bell DM. Occupational risk of infection with human immunodeficiency virus. Surg Clin North Am 1995;75:1057–1070.
79.Marcus R, Bell DM. Occupational risk of human immunodeficiency virus. In: Devita VT, Hellman S, Rosenberg SA, eds. AIDS: Etiology, Diagnosis, Treatment and Prevention. 4th ed. Philadelphia, PA: LippincottRaven; 1997:645–654.
80.Centers for Disease Control and Prevention. Update: provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV. MMWR 1996;45:468–472.
81.Centers for Disease Control and Prevention. Public Health Service (PHS) guidelines for the management of health care workers exposures to HIV and recommendations for postexposure prophylaxis. MMWR. In press.
82.Centers for Disease Control. Epidemic keratoconjunctivitis in an ophthalmology clinic—California. MMWR 1990;39:598–601.
83.Ford E, Nelson KE, Warren D. Epidemiology of epidemic keratoconjunctivitis. Epidemiol Rev 1987;9:244–261.
84.Birenbaum E, Linder N, Varsano N, Azar R, Kuint J, Spierer A, et al.Adenovirus type 8 conjunctivitis outbreak in a neonatal intensive care unit. Arch Dis Child 1993;68:610–611.
85.Warren D, Nelson KE, Farrar JA, Hurwitz E, Hierholzer J, Ford E, et al.A large outbreak of epidemic keratoconjunctivitis: problems in controlling nosocomial spread. J Infect Dis 1989;160:938–943.
86.Jernigan JA, Lowry BS, Hayden FG, Kyger SA, Conway BP, Gröschel DHM, et al.Adenovirus type 8 epidemic keratoconjunctivitis in an eye clinic: risk factors and control. J Infect Dis 1993;167:1307–1313.
87.Adler SP. Molecular epidemiology of cytomegalovirus: a study of factors affecting transmission among children at three day-care centers. Pediatr Infect Dis J 1991;10:584–590.
88.Adler SP, Bagget J, Wilson M, Lawrence L, McVoy M. Molecular epidemiology of cytomegalovirus in a nursery: lack of evidence for nosocomial transmission. J Pediatr 1986;108:117–123.
89.Meyers JD, Fluornoy N, Thomas ED. Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience. Rev Infect Dis 1982;3:1119–1132.
90.Bowden RA, Fisher LD, Rogers K, Cays M, Meyers JD. Cytomegalovirus (CMV)-specific intravenous immunoglobulin for the prevention of primary CMV infection and disease after marrow transplant. J Infect Dis 1991;164:483–487.
91.Brady MT, Demmler GJ, Reis S. Factors associated with cytomegalovirus excretion in hospitalized children. Am J Infect Control 1988;16:41–45.
92.Demmler GJ, Yow MD, Spector SA, Reis SC, Brady MT, Anderson DC, et al.Nosocomial cytomegalovirus infections within two hospitals caring for infants and children. J Infect Dis 1987;156:9–16.
93.Rubin RH, Wolfson JS, Cosimi AB, Tolkoff-Rubin NE. Infection in the renal transplant recipient. Am J Med 1981;70:405–411.
94.Pomeroy C, Englund JA. Cytomegalovirus: epidemiology and infection control. Am J Infect Control 1987;15:107–119.
95.Ahlfors K, Ivarsson SA, Johnson T, Renmarker K. Risk of cytomegalovirus infection in nurses and congenital infection in their offspring. Acta Paediatr Scand 1981;70:819–823.
96.Dworsky ME, Welch K, Cassady G, Stango S. Occupational risk for primary cytomegalovirus infection among pediatric health-care workers. N Engl J Med 1983;309:950–953.
97.Yeager AS. Longitudinal, serological study of cytomegalovirus infections in nurses and in personnel without patient contact. J Clin Microbiol 1975;2:448–452.
98.Gerberding JL, Bryant-LeBlanc CE, Nelson K, Moss AR, Osmond D, Chambers HF, et al.Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditions. J Infect Dis 1987;156:1–8.
99.Blackman JA, Murph JR, Bale JF. Risk of cytomegalovirus infection among educators and health care personnel serving disabled children. Pediatr Infect Dis J 1987;6:725–729.
100.Tolkoff-Rubin NE, Rubin RH, Keller EE, Baker GP, Stewart JA, Hirsh MS. Cytomegalovirus infection in dialysis patients and personnel. Ann Intern Med 1978;89:625–628.
101.Adler SP. Hospital transmission of cytomegalovirus. Infect Agents Dis 1992;1:43–49.
102.Balfour CL, Balfour HH. Cytomegalovirus is not an occupational risk for nurses in renal transplant and neonatal units. JAMA 1986;256:1909–1914.
103.Brady MT, Demmler GJ, Anderson DC. Cytomegalovirus infection in pediatric house officers: susceptibility to and new rate of primary infection. Infect Control 1987;8:329–332.
104.Lipscomb JA, Linneman CC, Hurst PF, Myers MG, Stringer W, Moore P, et al.Prevalence of cytomegalovirus antibody in nursing personnel. Infect Control 1984;5:513–518.
105.Friedman HM, Lewis MR, Nemerosky DM, Plotkin SA. Acquisition of cytomegalovirus infection among female employees at a pediatric hospital. Pediatr Infect Dis J 1984;3:233–235.
106.Balcarek KB, Bagley R, Cloud GA, Pass RF. Cytomegalovirus infection among employees of a children's hospital: no evidence for increased risk associated with patient care. JAMA 1990;263:840–844.
107.Tookey P, Peckham CS. Does cytomegalovirus present an occupational risk? Arch Dis Child 1991;66:1009–1010.
108.Hokeberg I, Grillner L, Reisenfeld T, Diderholm H. No evidence of hospital-acquired cytomegalovirus on environmental surfaces. Pediatr Infect Dis J 1988;7:812–814.
109.Yow MD, Lakeman AD, Stagno S, Reynolds RB, Plavidal FJ. Use of restriction enzymes to investigate the source of a primary cytomegalovirus infection in a pediatric nurse. Pediatrics 1982;70:713–716.
110.Wilfert CM, Huang E, Stagno S. Restriction endonuclease analysis of cytomegalovirus deoxyribonucleic acid as an epidemiologic tool. Pediatrics 1982;70:717–721.
111.Spector SA. Transmission of cytomegalovirus among infants in hospital documented by restriction-endonuclease-digestion analyses. Lancet 1983;2:378–381.
112.Pass RF, Hutto C, Lyon MD, Cloud G. Increased rate of cytomegalovirus infection among day care center workers. Pediatr Infect Dis J 1990;9:465–470.
113.Pass RF, Hutto C, Ricks R, Cloud GA. Increased rate of cytomegalovirus infection among parents of children attending daycare centers. N Engl J Med 1986;314:1414–1418.
114.Adler SP. Cytomegalovirus and child day care: evidence for an increased infection rate among day-care workers. N Engl J Med 1989;321:1290–1296.
115.Hutto C, Little EA, Ricks R. Isolation of cytomegalovirus from toys and hands in a day care center. J Infect Dis 1986;154:527–530.
116.Faix RG. Survival of cytomegalovirus on environmental surfaces. J Pediatr 1985;106:649–652.
117.Finney JW, Miller KM, Adler SP. Changing protective and risky behaviors to prevent child-to-parent transmission of cytomegalovirus. J Appl Behav Anal 1993;26:471–472.
118.Stagno S, Pass RF, Dworsky ME, Alford CA Jr. Maternal cytomegalovirus infection and perinatal transmission. Clin Obstet Gynecol 1982;25:563–576.
119.Onorato IM, Morens DM, Martone WJ, Stansfield SK. Epidemiology of cytomegaloviral infections: recommendations for prevention and control. Rev Infect Dis 1985;7:479–497.
120.Balcarek KB, Bagley R, Cloud GA. Nosocomial cytomegalovirus infections within two hospitals caring for infants and children. J Infect Dis 1987;145:9–16.
121.American Academy of Pediatrics. Summaries of infectious diseases: cytomegalovirus infection. In: Peter G, ed. 1997 Red Book: Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997:187–191.
122.Plotkin SA, Starr SE, Friedman HM, Gonczole E, Brayman K. Vaccines for the prevention of human cytomegalovirus infection. Rev Infect Dis 1990;12(suppl 7):S827–S838.
123.Adler SP, Starr SE, Plotkin SA, Hempfling SH, Buis J, Manning ML, et al.Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. J Infect Dis 1994;171:26–32.
124.Plotkin SA, Starr SE, Friedman HM, Brayman K, Harris S, Jackson S, et al.Effect of Towne live vaccine on cytomegalovirus disease after renal transplants: a controlled trial. Ann Intern Med 1991;114:525–531.
125.Fleisher GR, Starr SE, Friedman HM, Plotkin SA. Vaccination of pediatric nurses with live attenuated cytomegalovirus. Am J Dis Child 1982;136:294–296.
126.Snydman DR, Werner BG, Heinz-Lacy B, Berardi VP, Tilney NL, Kirkman RL, et al.Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N Engl J Med 1987;317:1049–1054.
127.Meyers JD, Reed EC, Shepp DH, Thornquist M, Dandliker PS, Vicary CA, et al.Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. N Engl J Med 1988;318:70–75.
128.Goodrich JM, Mori M, Gleaves CA, DuMond C, Cays M, Ebeling DF, et al.Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med 1991;325:1601–1607.
129.Bailey TC, Trulock EP, Ettinger NA, Storch GA, Cooper JD, Powderly WG. Failure of prophylactic ganciclovir to prevent cytomegalovirus disease in recipients of lung transplants. J Infect Dis 1992;165:548–552.
130.Hatherly LI. Is primary cytomegalovirus infection an occupational hazard for obstetric nurses? A serological study. Infect Control 1986;7:452–455.
131.Anderson GS, Penfold JB. An outbreak of diphtheria in a hospital for the mentally subnormal. J Clin Pathol 1973;26:606–615.
132.Gray RD, James SM. Occult diphtheria infection in a hospital for the mentally subnormal. Lancet 1973;1:1105–1106.
133.Palmer SR, Balfour AH, Jephcott AE. Immunisation of adults during an outbreak of diphtheria. BMJ 1983;286:624–626.
134.Bisgard KM, Hardy IRB, Popvic T, Strebel PM, Wharton M, Chen T, et al.Respiratory diphtheria in the United States, 1980-1995. Am J Public Health. In press.
135.Harnisch JP, Tronca E, Nolan CM, Turck M, Holmes KK. Diphtheria among alcoholic urban adults: a decade of experience in Seattle. Ann Intern Med 1989;111:71–82.
136.Centers for Disease Control and Prevention. Toxigenic Corynebacterium diphtheriae—northern plains Indian community, August-October 1996. MMWR 1997;46:506–510.
137.Centers for Disease Control and Prevention. Update: diphtheria epidemic—new independent states of the former Soviet Union, January 1995-March 1996. MMWR 1996;45:693–697.
138.Centers for Disease Control and Prevention. Diphtheria epidemic—new independent states of the former Soviet Union, 1990-1994. MMWR 1995;44:177–181.
139.Hardy IRB, Dittmann S, Sutter RW. Current situation and control strategies for resurgence of diphtheria in newly independent states of the former Soviet Union. Lancet 1996;347:1739–1744.
140.Centers for Disease Control and Prevention. Diphtheria outbreak—Saraburi Province, Thailand, 1994. MMWR 1996;45:271–273.
141.Lumio J, Jahkola M, Vuento R, Haikala O, Eskila J. Diphtheria after visit to Russia. Lancet 1993;342:53–54.
142.Centers for Disease Control and Prevention. Diphtheria acquired by US citizens in the Russian Federation and Ukraine—1994. MMWR 1995;44:237, 243–244.
143.American Academy of Pediatrics. Summaries of infectious diseases: diphtheria. In: Peter G, ed. 1997 Red Book: Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997:191–195.
144.Sargent RK, Rossing TH, Dowton SB, Breyer MD, Levine L, Weinstein L. Diphtheria immunity in Massachusetts—a study of three urban patient populations. Am J Med Sci 1984;287:37–39.
145.Weiss BP, Strassburg MA, Feeley JC. Tetanus and diphtheria immunity in an elderly population in Los Angeles County. Am J Public Health 1983;73:802–4.
146.Crossley K, Irvine P, Warren JB, Lee BK, Mead K. Tetanus and diphtheria immunity in urban Minnesota adults. JAMA 1979;242:2298–3000.
147.Ruben FL, Nagel J, Fireman P. Antitoxin responses in the elderly to tetanus-diphtheria (TD) immunization. Am J Epidemiol 1978;108:145–149.
148.Koblin BA, Townsend TR. Immunity to diphtheria and tetanus in inner-city women of childbearing age. Am J Public Health 1989;79:1297–1298.
149.Farizo KM, Strebel PM, Chen RT, Kimbler A, Cleary TJ, Cochi SL. Fatal respiratory disease due to Corynebacterium diphtheriae: case report and review of guidelines for management, investigation, and control. Clin Infect Dis 1993;16:59–68.
150.Steere AC, Craven PJ, Hall WJ III, Leotsukis N, Wells JG, Farmer JJ III, et al.Person-to-person spread of Salmonella typhimurium after a hospital common-source outbreak. Lancet 1975;1:319–322.
151.Blaser MJ, Hickman FW, Farmer JJ III, Brenner DJ, Balow SA, Feldman RA. Salmonella typhi: the laboratory as a reservoir of infection. J Infect Dis 1980;142:934–938.
152.Standaert SM, Hutcheson RH, Schaffner W. Nosocomial transmission of Salmonella gastroenteritis to laundry workers in a nursing home. Infect Control Hosp Epidemiol 1994;15:22–26.
153.Toivanen P, Toivanen A, Olkkonen L, Aantaa S. Hospital outbreak of Yersinia enterocolitica infection. Lancet 1973;1:801–803.
154.Ratnam S, Mercer E, Picco B, Parsons S, Butler R. A nosocomial outbreak of diarrheal disease due to Yersinia enterocolitica serotype 0:5, biotype 1. J Infect Dis 1982;145:242–247.
155.Anglim AM, Farr BM. Nosocomial gastrointestinal tract infections. In: Mayhall CG, ed. Hospital Epidemiology and Infection Control. Baltimore, MD: Williams & Wilkins; 1996:196–219.
156.Mitchell DK, Pickering LK. Nosocomial gastrointestinal tract infections in pediatric patients. In: Mayhall CG, ed. Hospital Epidemiology and Infection Control. Baltimore, MD: Williams & Wilkins; 1996:506–523.
157.McGowan JE Jr. Nosocomial infections in diagnostic laboratories. In: Mayhall CG, ed. Hospital Epidemiology and Infection Control. Baltimore, MD: Williams & Wilkins; 1996:883–892.
158.Kurtz JB, Lee TW, Pickering D. Astrovirus associated gastroenteritis in a children's ward. J Clin Pathol 1977;30:948–952.
159.Dryjanski J, Gold JWM, Ritchie MT, Kurtz RC, Lim SL, Armstrong D. Cryptosporidiosis: case report in a health team worker. Am J Med 1986;80:751–752.
160.Lewis DC, Lightfoot NF, Cubitt WD, Wilson SA. Outbreaks of astrovirus type 1 and rotovirus gastroenteritis in a geriatric in-patient population. J Hosp Infect 1989;14:9–14.
161.Koch KL, Phillips DJ, Aber RC, Current WL. Cryptosporidiosis in hospital personnel: evidence for person-to-person transmission. Ann Intern Med 1985;102:593–596.
162.Pike RM. Laboratory-associated infections: summary and analysis of 3921 cases. Health Lab Sci 1976;13:105–114.
163.Rodriguez EM, Parrott C, Rolka H, Monroe SS, Dwyer DM. An outbreak of viral gastroenteritis in a nursing home: importance of excluding ill employees. Infect Control Hosp Epidemiol 1996;17:587–592.
164.Gellert GA, Waterman SH, Ewert D, Oshiro L, Giles MP, Monroe SS, et al.An outbreak of acute gastroenteritis caused by a small round structured virus in a geriatric convalescent facility. Infect Control Hosp Epidemiol 1990;11:459–464.
165.Chadwick PR, McCann R. Transmission of a small round structured virus by vomiting during a hospital outbreak of gastroenteritis. J Hosp Infect 1994;26:251–259.
166.Linneman CC Jr, Cannon CG, Staneck JL, McNeely BL. Prolonged hospital epidemic of salmonellosis: use of trimethoprim-sulfamethoxazole for control. Infect Control 1985;6:221–225.
167.Tauxe RV, Hassan LF, Findeisen KO, Sharrar RG, Blake PA. Salmonellosis in nurses: lack of transmission to patients. J Infect Dis 1988;157:370–373.
168.Guerrant RL. Cryptosporidiosis: an emerging, highly infectious threat. Emerging Infect Dis 1997;3:51–57.
169.Schroeder SA, Aserkoff B, Brachman PS. Epidemic salmonellosis in hospitals and institutions: public health importance and outbreak management. N Engl J Med 1968;279:674–678.
170.Khuri-Bulos NA, Abu Khalaf M, Shehabi A, Shami K. Foodhandlerassociated Salmonella outbreak in a university hospital despite routine surveillance cultures of kitchen employees. Infect Control Hosp Epidemiol 1994;15:311–314.
171.Centers for Disease Control. Viral agents of gastroenteritis. MMWR 1990;39;(RR-5):1–24.
172.Caul EO. Small round structured viruses: airborne transmission and hospital control. Lancet 1994;343:1240–1242.
173.Noah ND. Airborne transmission of a small round structured virus. Lancet 1994;343:608–609.
174.Sawyer LA, Murphy JJ, Kaplan JE, Pinsky PF, Chacon D, Walmsley S, et al.25-to 30-nm virus particle associated with a hospital outbreak of acute gastroenteritis with evidence for airborne transmission. Am J Epidemiol 1988;127:1261–1271.
175.Sharp TW, Hyams KC, Watts D, Trofa AF, Martin GJ, Kapikian AZ, et al.Epidemiology of Norwalk virus during an outbreak of acute gastroenteritis aboard a US aircraft carrier. J Med Virol 1995;45:61–67.
176.Doebbeling BN, Stanley GL, Sheetz CT, Pfaller MA, Houston AK, Annis L, et al.Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N Engl J Med 1992;327:88–93.
177.Black DE, Dykes AC, Anderson KE, Wells JG, Sinclair SP, Gary GW, et al.Handwashing to prevent diarrhea in day care centers. Am J Epidemiol 1982;113:445–451.
178.Centers for Disease Control and Prevention. Typhoid immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1994;43(RR14):1–7.
179.Ho MS, Glass RI, Monroe SS, Madore HP, Stine S, Pinsky PF, et al.Viral gastroenteritis aboard a cruise ship. Lancet 1989;2:961–965.
180.Kilgore PE, Belay ED, Hamlin DM, Noel JS, Humphrey CD, Gary HE Jr, et al.A university outbreak of gastroenteritis due to a small round-structured virus: application of molecular diagnostics to identify the etiologic agent and patterns of transmission. J Infect Dis 1996;173:787–793.
181.Grohmann GS, Glass RI, Pereira HG, Monroe SS, Hightower AW, Weber R, et al.Enteric viruses and diarrhea in HIV-infected patients. N Engl J Med 1993;329:14–20.
182.Centers for Disease Control. Recommendations for collection of laboratory specimens associated with outbreaks of gastroenteritis. MMWR 1990;39(RR-14):1–13.
183.Salam MA, Bennish ML. Antimicrobial therapy for shigellosis. Rev Infect Dis 1991;13(suppl 4):S332–S341.
184.Allos BM, Blaser MJ. Campylobacter jejuni and the expanding spectrum of related infections. Clin Infect Dis 1995;20:1092–1099.
185.Buchwald DS, Blaser MJ. A review of human salmonellosis: II. duration of excretion following infection with nontyphi Salmonella. Rev Infect Dis 1984;6:345–356.
186.Aserkoff B, Bennett JV. Effect of antibiotic therapy in acute salmo-nellosis in the fecal excretion of Salmonellae. N Engl J Med 1969;281:636–640.
187.Pavia AT, Shipman LD, Wells JG, Puhr ND, Smith JD, McKinney TW, et al. Epidemiologic evidence that prior antimicrobial exposure decreases resistance to infection by antimicrobial-sensitive Salmonella. J Infect Dis 1990;161:255–260.
188.Miller SI, Hohmann EL, Pegues DA. Salmonella (including Salmonella typhi). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 4th ed. New York, NY: Churchill Livingstone; 1995:2013–2033.
189.Rosenblum LS, Villarino ME, Nainan OV, Melish ME, Hadler SC, Pinsley PP, et al.Hepatitis A outbreak in a neonatal intensive care unit: risk factors for transmission and evidence of prolonged viral excretion among preterm infants. J Infect Dis 1991;164:476–482.
190.Carl M, Kantor RJ, Webster HM, Fields MA, Maynard JE. Excretion of hepatitis A virus in the stools of hospitalized patients. J Med Virol 1982;9:125–12129.
191.Drusin LM, Sohmer M, Groshen SL, Spiritos MD, Senterfit LB, Christenson WN. Nosocomial hepatitis A infection in a paediatric intensive care unit. Arch Dis Child 1987;62:690–695.
192.Baptiste R, Koziol D, Henderson DK. Nosocomial transmission of hepatitis A in an adult population. Infect Control 1987;8:364–370.
193.Azimi PH, Roberto RR, Guralnik J, Livermore T, Hoag S, Hagens S, et al.Transfusion-acquired hepatitis A in a premature infant with secondary nosocomial spread in an intensive care nursery. Am J Dis Child 1986;140:23–27.
194.Goodman RA, Carder CC, Allen JR, Orenstein WA, Finton RJ. Nosocomial hepatitis A transmission by an adult patient with diarrhea. Am J Med 1982;73:220–226.
195.Skidmore SJ, Gully PR, Middleton JD, Hassam ZA, Singal GM. An outbreak of hepatitis A on a hospital ward. J Med Virol 1985;17:175–177.
196.Klein BS, Michaels JA, Rytel MW, Berg KG, Davis JP. Nosocomial hepatitis A: a multinursery outbreak in Wisconsin. JAMA 1984;252:2716–2721.
197.Krober MS, Bass JW, Brown JD, Lemon SM, Rupert KJ. Hospital outbreak of hepatitis A: risk factors for spread. Pediatr Infect Dis J 1984;3:296–299.
198.Reed CM, Gustafson TL, Siegel J, Duer P. Nosocomial transmission of hepatitis A from a hospital-acquired case. Pediatr Infect Dis J 1984;3:300–303.
199.Doebbeling BN, Li N, Wenzel RP. An outbreak of hepatitis A among health care workers: risk factors for transmission. Am J Public Health 1993;83:1679–1684.
200.Watson JC, Fleming DC, Borella AJ, Olcott ES, Conrad RE, Baron RC. Vertical transmission of hepatitis A resulting in an outbreak in a neonatal intensive care unit. J Infect Dis 1993;167:567–571.
201.Noble RC, Kane MA, Reeves SA, Roeckel I. Posttransfusion hepatitis A in a neonatal intensive care unit. JAMA 1984;252:2711–2715.
202.Lee KK, Vargo LR, Le CT, Fernando L. Transfusion-acquired hepatitis A outbreak from fresh frozen plasma in a neonatal intensive care unit. Pediatr Infect Dis J 1992;11:122–123.
203.Coulepis AG, Locarnini SA, Lehman NI, Gust ID. Detection of hepatitis A virus in the feces of patients with naturally acquired infections. J Infect Dis 1980;141:151–156.
204.Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996;45(RR-15):1–30.
205.Meyers JD, Romm FJ, Tihen WS, Bryan JA. Food-borne hepatitis A in a general hospital: epidemiologic study of an outbreak attributed to sandwiches. JAMA 1975;231:1049–1053.
206.Eisenstein AB, Aach RD, Jacobsohn W, Goldman A. An epidemic of infectious hepatitis in a general hospital: probable transmission by contaminated orange juice. JAMA 1963;185:171–174.
207.Papaevangelou GJ, Roumeliotou-Karayannis AJ, Contoyannis PC. The risk of nosocomial hepatitis A and B virus infections from patients under care without isolation precaution. J Med Virol 1981;7:143–148.
208.Kashiwagi S, Hayashi J, Ikematsu H, Nomura H, Kajiyama W, Ikematsu W, et al.Prevalence of immunologic markers of hepatitis A and B infection in hospital personnel in Miyazaki Prefecture, Japan. Am J Epidemiol 1985;122:960–969.
209.Van Dyke RB, Spector SA. Transmission of herpes simplex virus type 1 to a newborn infant during endotracheal suctioning for meconium aspiration. Pediatr Infect Dis J 1984;3:153–156.
210.Linneman CC, Buchman TG, Light IJ, Ballard JL. Transmission of herpes-simplex virus type 1 in a nursery for the newborn: identification of isolates by DNA ‘fingerprinting.’ Lancet 1978;1:964–966.
211.Kleiman MB, Schreiner RL, Eitzen H, Lemons JA, Jansen RD. Oral herpesvirus infection in nursery personnel: infection control policy. Pediatrics 1982;70:609–612.
212.Buchman TG, Roizman B, Adams G, Stover BH. Restriction endonu-clease fingerprinting of herpes simplex virus DNA: a novel epidemiological tool applied to a nosocomial outbreak. J Infect Dis 1978;138:488–498.
213.Greaves WL, Kaiser AB, Alford RH, Schaffner W. The problem of herpetic whitlow among hospital personnel. Infect Control 1980;1:381–385.
214.Adams G, Stover BH, Keenlyside RA, Hooton TM, Buchman TG, Roizman B, et al.Nosocomial herpetic infections in a pediatric intensive care unit. Am J Epidemiol 1981;113:126–132.
215.American Academy of Pediatrics. Summaries of infectious diseases: herpes simplex. In: Peter G, ed. 1997 Red Book: Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997:266–276.
216.Pereira FA. Herpes simplex: evolving concepts. J Am Acad Dermatol 1996;35:503–520.
217.Perl TM, Haugen TH, Pfaller MA, Hollis R, Lakeman AD, Whitley RJ, et al.Transmission of herpes simplex virus type 1 infection in an intensive care unit. Ann Intern Med 1992;117:584–586.
218.Turner R, Shehab Z, Osborne K, Hendley JO. Shedding and survival of herpes simplex virus from ‘fever blisters.’ Pediatrics 1982;70:547–549.
219.Spruance SL, Overall JC Jr, Kern ER, Krueger GG, Pliam V, Miller W. The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. N Engl J Med 1977;297:69–75.
220.Davis RM, Orenstein WA, Frank JA Jr, Sacks JJ, Dales LG, Preblud SR, et al.Transmission of measles in medical settings, 1980 through 1984. JAMA 1986;255:1295–1298.
221.Atkinson WL, Markowitz LE, Adams NC, Seastrom GR. Transmis sion of measles in medical settings—United States, 1985-1989. Am J Med 1991;91(suppl 3B):320S–324S.
222.Raad II, Sheretz RJ, Rains CS, Cusick JL, Fauerbach LL, Reuman PD, et al.The importance of nosocomial transmission of measles in the propagation of a community outbreak. Infect Control Hosp Epidemiol 1989;10:161–166.
223.Istre GR, McKee PA, West GR, O'Mara DJ, Rettig PJ, Stuemky J, et al. Measles spread in hospital settings: an important focus of disease transmission? Pediatrics 1987;79:356–358.
224.Dales LG, Kizer KW. Measles transmission in medical facilities. West J Med 1985;142:415–416.
225.Sienko DG, Friedman C, McGee HB, Allen MJ, Simeson WF, Wentworth BB, et al.A measles outbreak at university medical setting involving medical health care providers. Am J Public Health 1987;77:1222–1224.
226.Rivera ME, Mason WH, Ross LA, Wright HT Jr. Nosocomial measles infection in a pediatric hospital during a community-wide epidemic. J Pediatr 1991;119:183–186.
227.Rank EL, Brettman L, Katz-Pollack H, DeHertogh D, Neville D. Chronology of a hospital-wide measles outbreak: lessons learned and shared from an extraordinary week in late March 1989. Am J Infect Control 1992;209:315–318.
228.Watkins NM, Smith RP Jr, St Germain DL, MacKay DN. Measles (rubeola) infection in a hospital setting. Am J Infect Control 1987;15:201–206.
229.Remington PL, Hall WN, Davis IH, Herald A, Gunn RA. Airborne transmission of measles in a physician's office. JAMA 1985;253:1574–1577.
230.Atkinson WL. Measles and health care workers. Infect Control Hosp Epidemiol 1994;15:5–7.
231.Bloch AB, Orenstein WA, Ewing WM. Measles outbreak in a pediatric practice: airborne transmission in an office setting. Pediatrics 1985;75:676–683.
232.American Academy of Pediatrics. Summaries of infectious diseases: measles. In: Peter G, ed. 1997 Red Book: Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997:334–357.
233.Braunstein H, Thomas S, Ito R. Immunity to measles in a large population of varying age. Am J Dis Child 1990;144:296–298.
234.Smith E, Welch W, Berhow M, Wong VK. Measles susceptibility of hospital employees as determined by ELISA. Clin Res 1990;38:183A. Abstract.
235.Subbarao EK, Amin S, Kumar ML. Prevaccination serologic screening for measles in health care workers. J Infect Dis 1991;163:876–878.
236.Sellick J Jr, Longbine D, Schiffeling R, Mylotte JM. Screening hospital employees for measles immunity is more cost effective than blind immunization. Ann Intern Med 1992;116:982–984.
237.Grabowsky M, Markowitz LE. Serologic screening, mass immunization, and implications for immunization programs. J Infect Dis 1991;164:1237–1238.
238.Stover BH, Adams G, Kuebler CA, Cost KM, Rabalais GP. Measlesmumps-rubella immunization of susceptible hospital employees during a community measles outbreak: cost-effectiveness and protective efficacy. Infect Control Hosp Epidemiol 1994;15:18–21.
239.Jackson LA, Schuchat A, Reeves NW, Wenger JD. Serogroup C meningococcal outbreaks in the United States: an emerging threat. JAMA 1995;273:383–389.
240.Houck P, Patnode M, Atwood R, Powell K. Epidemiologic characteristics of an outbreak of serogroup C meningococcal disease and the public health response. Public Health Rep 1995;110:343–349.
241.Centers for Disease Control. Laboratory-acquired meningococcemia—California and Massachusetts. MMWR 1991;40:46-47, 55.
242.Centers for Disease Control. Nosocomial meningococcemia—Wisconsin. MMWR 1978;27:358–363.
243.Rose HD, Lenz IE, Sheth NK. Meningococcal pneumonia: a source of nosocomial infection. Arch Intern Med 1981;141:575–577.
244.Cohen MS, Steere AC, Baltimore R, von Graevenitz A, Pantelick E, Camp B, et al.Possible nosocomial transmission of group Y Neisseria meningitidis among oncology patients. Ann Intern Med 1979;91:7–12.
245.Broome CV. The carrier state: Neisseria meningitidis. J Antimicrob Chemother 1986;18(suppl A):25–34.
246.Gaunt PN, Lambert BE. Single dose ciprofloxacin for the eradication of pharyngeal carriage of Neisseria meningitidis. J Antimicrob Chemother 1988;21:489–496.
247.Munford RS, Taunay A, de Morais JS, Fraser DW, Feldman RA. Spread of meningococcal infection within households. Lancet 1974;1:1275–1278.
248.American Academy of Pediatrics. Meningococcal disease prevention and control strategies for practice-based physicians. Pediatrics 1996;97:404–411.
249.Riedo FX, Plikaytis BD, Broome CV. Epidemiology and prevention of meningococcal disease. Pediatr Infect Dis J 1995;14:643–657.
250.Griffis JM. Epidemic meningococcal disease: synthesis of a hypothetical immunoepidemiologic model. Rev Infect Dis 1982;4:159–172.
251.Caugant DA, Hoiby EA, Magnus P, Scheel O, Hoel T, Bjune G, et al.Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol 1994;32:323–330.
252.Caugant DA, Hoiby EA, Rosenqvist E, Froholm LO, Selander RK. Transmission of Neisseria meningitidis among asymptomatic military recruits and antibody analysis. Epidemiol Infect 1992;109:241–253.
253.Wharton M, Cochi SL, Hutcheson RH, Schaffner W. Mumps transmission in hospitals. Arch Intern Med 1990;150:47–49.
254.Fischer PR, Brunetti C, Welch V, Christenson JC. Nosocomial mumps: report of an outbreak and its control. Am J Infect Control 1996;24:13–18.
255.American Academy of Pediatrics. Summaries of infectious diseases: mumps. In: Peter G, ed. 1997 Red Book: Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997:366–369.
256.Williams WW, Preblud SR, Reichelderfer PS, Hadler SC. Vaccines of importance in the hospital setting: problems and developments. Infect Dis Clin North Am 1989;3:701–722.
257.Koplan JP, Preblud SR. A benefit-cost analysis of mumps vaccine. Am J Dis Child 1982;136:362–364.
258.Hersh BS, Fine PEM, Kent WK, Cochi SL, Kahn LH, Zell ER, et al.Mumps outbreak in a highly vaccinated population. J Pediatr 1991;119:187–193.
259.Anderson LJ, Török TJ. The clinical spectrum of human parvovirus B19 infections. Curr Clin Top Infect Dis 1991;11:267–280.
260.Török TJ. Parvovirus B19 and human disease. Adv Intern Med 1992;37:431–455.
261.Shishiba T, Matsunaga Y. An outbreak of erythema infectiosum among hospital staff members including a patient with pleural fluid and pericardial effusion. J Am Acad Dermatol 1993;29:265–267.
262.Seng C, Watkins P, Morse D, Barrett SP, Zambon M, Andrews N, et al.Parvovirus B19 outbreak on an adult ward. Epidemiol Infect 1994;113:345–353.
263.Bell LM, Naides J, Stoffman P, Hodinka RL, Plotkin SA. Human parvovirus B19 infection among hospital staff members after contact with infected patients. N Engl J Med 1989;321:485–491.
264.Harrison J, Jones DE. Human parvovirus B19 in health care workers. Occup Med 1995;45:93–96.
265.Pillay D, Patou G, Hurt S, Kibbler CC, Griffiths PD. Parvovirus B19 outbreak in a children's ward. Lancet 1992;339:107–109.
266.Dowell SF, Török TJ, Thorp JA, Hedrick J, Erdman DD, Zaki SR, et al.Parvovirus B19 infection in hospital workers: community or hospital acquisition. J Infect Dis 1995;172:1076–109.
267.Ray SM, Erdman DD, Berschling JD, Cooper JE, Török TJ, Blumberg HM, et al.Nosocomial exposure to parvovirus B19: low risk of transmission to healthcare workers. Infect Control Hosp Epidemiol 1997;18:109–114.
268.Koziol DE, Kurtzman G, Ayub J, Young NS, Henderson DK. Nosocomial human parvovirus B19 infection: lack of transmission from a chronically infected patient to hospital staff. Infect Control Hosp Epidemiol 1992;13:343–348.
269.Evans JP, Rossiter MA, Kumaran TO, Marsh GW, Mortimer PP. Human parvovirus aplasia: case due to cross infection in a ward. BMJ 1984;288:681.
270.Cohen BJ, Courouce AM, Schwartz TF, Okochi K, Kurtzman GJ. Laboratory infection with parvovirus B19. J Clin Pathol 1988;41:1027–1028. Letter.
271.Anderson MJ, Gillespie SM, Török TJ, Hurwitz ES, Tsou J, Gary GW. Risk of infection following exposures to human parvovirus B19. Behring Inst Mitt 1990;85:60–63.
272.Anderson MJ, Lewis E, Kidd IM, Hall SM, Cohen BJ. An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg 1984;93:85–93.
273.Chorba T, Coccia P, Holman RC, Tattersall P, Anderson LJ, Sudman J, et al.The role of parvovirus B19 in aplastic crisis and erythema infectiosum. J Infect Dis 1986;154:383–393.
274.Török TJ. Human parvovirus B19. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant. 4th ed. Philadelphia, PA: WB Saunders; 1995:668–702.
275.Török TJ. Human parvovirus B19 infections in pregnancy. Pediatr Infect Dis J 1990;9:772–776.
276.Kurt TL, Yeager AS, Guennette S, Dunlop S. Spread of pertussis by hospital staff. JAMA 1972;221:264–267.
277.Linneman CC Jr, Ramundo N, Perlstein PH, Minton SD, Englender GS. Use of pertussis vaccine in an epidemic involving hospital staff. Lancet 1975;2:540–543.
278.Valenti WM, Pincus PH, Messner MK. Nosocomial pertussis: possible spread by a hospital visitor. Am J Dis Child 1980;134:520–521.
279.Christie C, Glover AM, Willke MJ, Marx ML, Reising SF, Hutchinson NM. Containment of pertussis in the regional pediatric hospital during the greater Cincinnati epidemic of 1993. Infect Control Hosp Epi demiol 1995;16:556–563.
280.Shefer A, Dales L, Nelson M, Werner B, Baron R, Jackson R. Use and safety of acellular pertussis vaccine among adult hospital staff during an outbreak of pertussis. J Infect Dis 1995;171:1053–1056.
281.Deville JG, Cherry JD, Christenson PD, Pineda E, Leach CT, Kuhls TL, et al.Frequency of unrecognized Bordetella pertussis in adults. Clin Infect Dis 1995;21:639–642.
282.Nennig ME, Shinefield HR, Edwards KM, Black SB, Fireman BH. Prevalence and incidence of adult pertussis in an urban population. JAMA 1996;275:1672–1674.
283.Mortimer EA Jr. Pertussis vaccine. In: Plotkin SA, Mortimer EA Jr, eds. Vaccines. Philadelphia, PA: WB Saunders; 1994:91–137.
284.Mortimer EA Jr. Pertussis and its prevention: a family affair. J Infect Dis 1990;161:473–479.
285.Deen JL, Mink CA, Cherry JD, Christenson PD, Pineda EF, Lewis K, et al.Household contact study of Bordetella pertussis infections. Clin Infect Dis 1995;21:1211–1219.
286.Edwards KM, Decker MD, Graham BS, Mozzatesta J, Scott J, Hackell J. Adult immunization with acellular pertussis vaccine. JAMA 1993;269:53–56.
287.Weber DJ, Rutala WA. Management of healthcare workers exposed to pertussis. Infect Control Hosp Epidemiol 1994;15:411–415.
288.Halsey NA, Welling MA, Lehman RM. Nosocomial pertussis: a failure of erythromycin treatment and prophylaxis. Am J Dis Child 1980; 134:521–522.
289.Centers for Disease Control and Prevention. Paralytic poliomyelitis— United States, 1980-1994. MMWR 1997;46:79–83.
290.American Academy of Pediatrics. Summaries of infectious diseases: poliovirus infections. In: Peter G, ed. 1997 Red Book: Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997:424–433.
291.Fishbein DB, Robinson LE. Current concepts: rabies. N Engl J Med 1997;329:1632–1638.
292.Winkler WG, Fashinell TR, Leffingwell L, Howard P, Conomy JP. Airborne rabies transmission in a laboratory worker. JAMA 1973;226:1219–1221.
293.Centers for Disease Control. Rabies in a laboratory worker—New York. MMWR 1977;26:183–184.
294.Helmick CG, Tauxe RV, Vernon AA. Is there a risk to contacts of patients with rabies? Rev Infect Dis 1987;9:511–518.
295.Centers for Disease Control and Prevention. Human rabies—New Hampshire, 1996. MMWR 1997;46:267–270.
296.Centers for Disease Control and Prevention. Human rabies—Connecticut, 1995. MMWR 1996;45:207–209.
297.Centers for Disease Control and Prevention. Human rabies—Washington, 1995. MMWR 1995;44:625–627.
298.Greaves WL, Orenstein WA, Stetler HC, Preblud SR, Hinman AR, Bart KJ. Prevention of rubella transmission in medical facilities. JAMA 1982;248:861–864.
299.Centers for Disease Control. Rubella in hospitals—California. MMWR 1983;32:37–39.
300.Poland GA, Nichol KL. Medical students as sources of rubella and measles outbreaks. Arch Intern Med 1990;150:44–46.
301.Storch GA, Gruber C, Benz B, Beaudoin J, Hayes J. A rubella outbreak among dental students: description of the outbreak and analysis of control measures. Infect Control 1985;6:150–156.
302.Strassburg MA, Stephenson TG, Habel LA, Fannin SL. Rubella in hospital employees. Infect Control 1984;5:123–126.
303.Fliegel PE, Weinstein WM. Rubella outbreak in a prenatal clinic: management and prevention. Am J Infect Control 1982;10:29–33.
304.Strassburg MA, Imagawa DT, Fannin SL, Turner JA, Chow AW, Murray RA, et al.Rubella outbreak among hospital employees. Obstet Gynecol 1981;57:283–288.
305.Gladstone JL, Millian SJ. Rubella exposure in an obstetric clinic. Obstet Gynecol 1981;57:182–186.
306.American Academy of Pediatrics. Summaries of infectious diseases: rubella. In: Peter G, ed. 1997 Red Book: Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997:456–462.
307.Polk FB, White JA, DeGirolami PC, Modlin JF. An outbreak of rubella among hospital personnel. N Engl J Med 1980;303:541–545.
308.Sachs JJ, Olson B, Soter J, Clark C. Employee rubella screening programs in Arizona hospitals. JAMA 1983;249:2675–2678.
309.Preblud SR. Some current issues relating to the rubella vaccine. JAMA 1985;254:253–256.
310.Lettau LA. Nosocomial transmission and infection control aspects of parasitic and ectoparasitic diseases, part III: ectoparasites/summary and conclusions. Infect Control Hosp Epidemiol 1991;12:179–185.
311.Juranek DD, Currier RW, Millikan LE. Scabies control in institutions. In: Orkin M, Maiback HI, eds. Cutaneous Infestations and Insect Bites. New York, NY: Dekker; 1985:139–156.
312.Jucowics P, Ramon ME, Don PC, Stone RK, Bamji M. Norwegian scabies in an infant with acquired immunodeficiency syndrome. Arch Dermatol 1989;125:1670–1671.
313.Hench C, Paulson SS, Stevens DA, Thompson JD. Scabies outbreak on a spinal cord injury unit. Rehabil Nurs 1994;19:21–23.
314.Jimenez-Lucho VE, Fallon F, Caputo C, Ramsey K. Role of prolonged surveillance in the eradication of nosocomial scabies in an extended care Veterans Affairs medical center. Am J Infect Control 1995;23:44–49.
315.Degelau J. Scabies in long-term care facilities. Infect Control Hosp Epidemiol 1992;13:421–425.
316.Lerche NW, Currier RW, Juranek DD, Baer W, Dubay NJ. Atypical crusted ‘Norwegian’ scabies: report of nosocomial transmission in a community hospital and an approach to control. Cutis 1983;31:668–684.
317.Lempert KD, Baltz PS, Welton WA, Whittier FC. Pseudouremic pruritus: a scabies epidemic in a dialysis unit. Am J Kidney Dis 1985;5:117–119.
318.Thomas MC, Giedinghagen DH, Hoff GL. Brief report: an outbreak of scabies among employees in a hospital-associated commercial laundry. Infect Control 1987;8:427–429.
319.Centers for Disease Control. Scabies in health-care facilities—Iowa. MMWR 1988;37:178–179.
320.Orkin M. Scabies in AIDS. Semin Dermatol 1993;12:9–14.
321.Lam S, Brennessel D. Norwegian scabies and HIV infection—case report and literature review. Infect Dis Clin Practice 1993;3:169–173.
322.Gooch JJ, Strasius SR, Beamer B, Reiter MD, Correll GW. Nosocomial outbreak of scabies. Arch Dermatol 1978;114:897–898.
323.Corbett EL, Crossley I, Holton J, Levell N, Miller RF, DeCock KM. Crusted (‘Norwegian’) scabies in a specialist HIV unit: successful use of ivermectin and failure to prevent nosocomial transmission. Genitourin Med 1996;72:115–117.
324.Taplin D, Rivera A, Walker JG, Roth WI, Reno D, Meinking T. A comparative trial of three treatment schedules for the eradication of scabies. J Am Acad Dermatol 1983;9:550–554.
325.Arlian LG, Estes SA, Vyszenski-Moher DL. Prevalence of Sarcoptes scabei in the homes and nursing homes of scabietic patients. J Am Acad Dermatol 1988;19:806–811.
326.Estes SA, Estes J. Therapy of scabies: nursing homes, hospitals, and the homeless. Semin Dermatol 1993;12:26–33.
327.Sargent SJ. Ectoparasites. In: Mayhall CG, ed. Hospital Epidemiology and Infection Control. Baltimore, MD: Williams & Wilkins; 1996:465–472.
328.Centers for Disease Control and Prevention. 1998 guidelines for treatment of sexually transmitted diseases MMWR 1998;47(RR-1):105–108.
329.Brown S, Becher J, Brady W. Treatment of ectoparasitic infections: review of the English-language literature, 1982-1992. Clin Infect Dis 1995;20(suppl 1):S104–S109.
330. Anonymous. Drugs for parasitic infections. Med Lett Drugs Ther 1995;37:102, 105.
331.American Academy of Pediatrics. Summaries of infectious diseases: scabies. In: Peter G, ed. 1997 Red Book: Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997:468–470.
332.Mienking TL, Taplan D, Hermida JL, Pardo R, Kerdel FA. The treatment of scabies with ivermectin. N Engl J Med 1995;333:26–30.
333.Hopper AH, Salisbury J, Jegadeva AN, Scott B, Bennett GCS. Epidemic Norwegian scabies in a geriatric unit. Age Ageing 1990;19:125–127.
334.Taplin D, Arrue C, Walker JG, Roth WI, Rivera A. Eradication of scabies with a single treatment schedule. J Am Acad Dermatol 1983;9:546–550.
335.Juranek DD. Pediculosis capitis in school children: epidemiologic trends, risk factors, and recommendations for control. In: Orkin M, Maiback HI, eds. Cutaneous Infestations and Insect Bites. New York, NY: Dekker; 1985:199–211.
336.Wenzel RP. Healthcare workers and the incidence of nosocomial infection: can treatment of one influence the other? A brief review. J Chemother 1994;6(suppl 4):33-37, 39–40.
337.Panlilio AL, Culver DH, Gaynes RP, Banerjee S, Henderson TS, Tolson JS, et al.Methicillin-resistant Staphylococcus aureus in US hospitals, 1975-1991. Infect Control Hosp Epidemiol 1992;13:582–586.
338.Boyce JM. Methicillin-resistant Staphylococcus aureus: Detection, epidemiology and control measures. Infect Dis Clin North Am 1989;3:901–913.
339.Boyce JM. Methicillin-resistant Staphylococcus aureus in hospitals and long-term care facilities: microbiology, epidemiology, and preventive measures. Infect Control Hosp Epidemiol 1992;13:725–737.
340.Boyce JM. Should we vigorously try to contain and control methi-cillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol 1991;12:46–54.
341.Boyce JM, Opal SM, Byone-Potter G, Medeiros AA. Spread of methicillin-resistant Staphylococcus aureus in a hospital after exposure to a health care worker with chronic sinusitis. Clin Infect Dis 1993;17:496–504.
342.Sherertz RJ, Reagan DR, Hampton KD, Robertson KL, Streed SA, Hoen HM, et al.A cloud adult: the Staphylococcus aureus-virus interaction revisited. Ann Intern Med 1996;124:539–547.
343.Belani A, Sherertz RJ, Sullivan ML, Russel BA, Reumen PD. Outbreak of staphylococcal infection in two hospital nurseries traced to a single nasal carrier. Infect Control 1986;7:487–490.
344.Kreiswirth BN, Kravitz GR, Schlievert PM, Novick RP. Nosocomial transmission of a strain of Staphylococcus aureus causing toxic shock syndrome. Ann Intern Med 1986;105:704–707.
345.Villarino ME, Vugia DJ, Bean NH, Jarvis WR, Hughes JM. Foodborne disease prevention in health care facilities. In: Bennett JV, Brachman PS, eds. Hospital Infections. 3rd ed. Boston: Little, Brown and Co; 1992:345–358.
346.Layton MC, Perez M, Heald P, Patterson JE. An outbreak of mupirocin-resistant Staphylococcus aureus on a dermatology ward associated with an environmental reservoir. Infect Control Hosp Epidemiol 1993;14:369–375.
347.American Academy of Pediatrics. Summaries of infectious diseases: staphylococcal infections. In: Peter G, ed. 1997 Red Book: Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997:476–482.
348.Boyce JM, Landry M, Deetz TR, DuPont HL. Epidemiologic studies of an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections. Infect Control 1981;2:110–116.
349.Walsh TJ, Standiford HD, Reboli AC, John JF, Mulligan ME, Ribner BS, et al.Randomized double-blinded trial of rifampin with either novo-biocin or trimethoprim sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome. Antimicrob Agents Chemother 1993;37:1334–1342.
350.Mulligan ME, Murray-Leisure KA, Ribner BS, Standiford HC, John JF, Korvick JA, et al.Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993;94:313–328.
351.Reboli AC, John JF, Platt CG, Cantley JR. Methicillin-resistant Staphy-lococcus aureus outbreak at a Veterans' Affairs medical center: importance of carriage of the organism by hospital personnel. Infect Control Hosp Epidemiol 1990;11:291–296.
352.Reagan DR, Doebbeling BN, Pfaller MA, Sheetz CT, Houston AK, Hollis RJ, et al.Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med 1991;114:101–106.
353.Chambers HF. Treatment of infection and colonization caused by methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 1991;12:29–35.
354.Kauffman CA, Terpenning MS, He X, Zaring LT, Ramsey MA, Jorgensen KA, et al.Attempts to eradicate methicillin-resistant Staphylo-coccus aureus from a long-term-care facility with the use of mupirocin ointment. Am J Med 1993;94:371–378.
355.Wenzel RP, Nettleman MD, Jones RN, Pealler MA. Methicillin-resistant Staphylococcus aureus: implications for the 1990s and effective control measures. Am J Med 1991;91(suppl 3B):221S–227S.
356.Doebbeling BN, Breneman DL, Neu HC, Aly R, Yangco BG, Holley HP Jr, et al.Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. Clin Infect Dis 1993;17:466–474.
357.Doebbeling BN, Reagan DR, Pfaller MA, Houston AK, Hollis RJ, Wenzel RP. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage. Arch Intern Med 1994;154:1505–1508.
358.Smith SM, Eng RH, Tecson-Tumang F. Ciprofloxacin therapy for methicillin-resistant Staphylococcus aureus infections or colonization. Antimicrob Agents Chemother 1989;33:181–184.
359.Darouiche R, Wright C, Hamill R, Koza M, Lewis D, Markowski J. Eradication of colonization by methicillin-resistant Staphylococcus aureus by using oral minocycline-rifampin and topical mupirocin. Antimicrob Agents Chemother 1991;35:1612–1615.
360.Arathoon EG, Hamilton JR, Hench CE, Stevens DA. Efficacy of short courses of oral novobiocin-rifampin in eradicating carrier state of methicillin-resistant Staphylococcus aureus and in vitro killing studies of clinical isolates. Antimicrob Agents Chemother 1990;34:1655–1659.
361.Bartzokas CA, Paton JH, Gibson MF, Graham F, McLoughlin GA, Croton RS. Control and eradication of methicillin-resistant Staphylo-coccus aureus on a surgical unit. N Engl J Med 1984;311:1422–1425.
362.Ward TT, Winn RE, Hartstein AL, Sewell DL. Observations relating to an inter-hospital outbreak of methicillin-resistant Staphylococcus aureus: role of antimicrobial therapy in infection control. Infect Control 1981;2:453–459.
363.Boyce JM, Jackson MM, Pugliese G, Batt MD, Fleming D, Garner JS, et al.Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. Infect Control Hosp Epidemiol 1994;15:105–115.
364.Strasbaugh LJ, Jacobson C, Sewell DL, Potter S, Ward TT. Antimicrobial therapy for methicillin-resistant Staphylococcus aureus colonization in residents and staff of a Veterans Affairs nursing home care unit. Infect Control Hosp Epidemiol 1992;13:151–159.
365.Miller MA, Dascal A, Portnoy J, Mendelson J. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 1996;17:811–813.
366.Santos KRN, Fonseca LS, Filho PPG. Emergence of high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolated from Brazilian university hospitals. Infect Control Hosp Epidemiol 1996;17:813–816.
367.Valenzuela TD, Hooton TM, Kaplan EL, Schlievert PM. Transmission of toxic strep syndrome from an infected child to a firefighter during CPR. Ann Emerg Med 1991;20:90–92.
368.Rammelkamp CH, Mortimer EA, Wolinsky E. Transmission of strep-tococcal and staphylococcal infection. Ann Intern Med 1964;60:753–758.
369.Weber DJ, Rutala WA, Denny FW Jr. Management of healthcare workers with pharyngitis or suspected streptococcal infections. Infect Control Hosp Epidemiol 1996;17:753–761.
370.Mastro TD, Farley TA, Elliott JA, Facklam RR, Perks JR, Hadler JL, et al.An outbreak of surgical-wound infections due to group A streptococcus carried on the scalp. N Engl J Med 1990;323:968–972.
371.Viglionese A, Nottebart VF, Bodman HA, Platt R. Recurrent group A streptococcal carriage in a health care worker associated with widely separated nosocomial outbreaks. Am J Med 1991;91(suppl 3B): 329S–333S.
372.Paul SM, Genese C, Spitalny K. Postoperative group A-hemolytic streptococcus outbreak with the pathogen traced to a member of a healthcare worker's household. Infect Control Hosp Epidemiol 1990;11:643–646.
373.Ridgway EJ, Allen KD. Clustering of group A streptococcal infections on a burns unit: important lessons in outbreak management. J Hosp Infect 1993;25:173–182.
374.Berkelman RL, Martin D, Graham DR, Mowry J, Freisem R, Weber JA, et al.Streptococcal wound infections caused by a vaginal carrier. JAMA 1982;247:2680–2682.
375.Schaffner W, Lefkowitz LB Jr, Goodman JS, Koenig MG. Hospital outbreak of infections with group A streptococci traced to an asymptomatic anal carrier. N Engl J Med 1969;280:1224–1225.
376.Richman DD, Breton SJ, Goldmann DA. Scarlet fever and group A streptococcal surgical wound infection traced to an anal carrier. J Pediatr 1977;90:387–390.
377.Decker MD, Lavely GB, Hutcheson RHJ, Schaffner W. Food-borne streptococcal pharyngitis in a hospital pediatrics clinic. JAMA 1986;253:679–681.
378.Stromberg A, Schwan A, Cars O. Throat carrier rates of beta-hemolytic streptococci among healthy adults and children. Scand J Infect Dis 1988;20:411–417.
379.Stamm WE, Feeley JC, Facklam RR. Wound infection due to group A streptococcus traced to a vaginal carrier. J Infect Dis 1978;138:287–292.
380.American Academy of Pediatrics. Summaries of infectious diseases: group A streptococcal infections. In: Peter G, ed. 1997 Red Book: Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997:483–494.
381.Barnes PF, Bloch AB, Davidson PT, Snider DE. Tuberculosis in patients with human immunodeficiency syndrome. N Engl J Med 1991;324:1644–1650.
382.Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. MMWR 1994;43(RR-13):1–132.
383.Edlin BR, Tokars JI, Grieco MH, Crawford JT, Williams J, Sordillo EM, et al.An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992;326:1514–1521.
384.Stroud LA, Tokars JI, Grieco MH, Crawford JT, Culver DH, Edlin BR, et al.Evaluation of infection control measures in preventing the nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in a New York City hospital. Infect Control Hosp Epidemiol 1995;16:141–147.
385.Beck-Sagué CM, Dooley SW, Hutton MD, Otten J, Breeden A, Crawford JT, et al.Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections: factors in transmission to staff and HIV-infected patients. JAMA 1992;268:1280–1286.
386.Wenger PN, Otten J, Breeden A, Orfas E, Beck-Sagué CM, Jarvis WR. Control of nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis among healthcare workers and HIV- infected patients. Lancet 1995;345:235–240.
387.Dooley SW, Villarino ME, Lawrence M, Salinas L, Amil S, Rullan JV, et al.Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients. JAMA 1992;267:2632–2635.
388.Pearson ML, Jereb JA, Frieden TR, Crawford JT, Davis BJ, Dooley SW, et al.Nosocomial transmission of multidrug-resistant Mycobac-terium tuberculosis: a risk to patients and health care workers. Ann Intern Med 1992;117:191–196.
389.Cleveland JL, Kent J, Gooch BF, Valway SE, Marianos DW, Butler WR, et al.Multidrug-resistant Mycobacterium tuberculosis in an HIV dental clinic. Infect Control Hosp Epidemiol 1995;16:7–11.
390.Ridzon R, Kenyon T, Luskin-Hawk R, Schultz C, Valway S, Onorato IM. Nosocomial transmission of human immunodeficiency virus and subsequent transmission of multidrug-resistant tuberculosis in a healthcare worker. Infect Control Hosp Epidemiol 1997;18:422–423.
391.Jereb JA, Klevens M, Privett TD, Smith PJ, Crawford JT, Sharp VL, et al.Tuberculosis in health care workers at a hospital with an outbreak of multidrug-resistant Mycobacterium tuberculosis. Arch Intern Med 1995;155:854–859.
392.Sepkowitz KA. Tuberculosis and the health care worker: a historical perspective. Ann Intern Med 1994;120:71–79.
393.Menzies D, Fanning A, Yuan L, Fitzgerald M. Tuberculosis among health care workers. N Engl J Med 1995;332:92–98.
394.McKenna MT, Hutton MD, Cauthen G, Onorato IM. The association between occupation and tuberculosis: a population based survey. Am J Respir Crit Care Med 1996;154:587–589.
395.Zaza S, Blumberg HM, Beck-Sagué C, Haas WH, Woodley CL, Pineda M, et al.Nosocomial transmission of Mycobacterium tuberculosis: role of health care workers in outbreak propagation. J Infect Dis 1995; 172:1542–1549.
396.Jarvis WR. Nosocomial transmission of multidrug-resistant Mycobac-terium tuberculosis. Am J Infect Control 1995;23:146–151.
397.Ikeda RM, Birkhead GS, DiFerdinando GT Jr, Bornstein DL, Dooley SW, Kubica GP, et al.Nosocomial tuberculosis: an outbreak of a strain resistant to seven drugs. Infect Control Hosp Epidemiol 1995;16:152–159.
398.Ussery XT, Bierman JA, Valway S, Seitz TA, DiFerdinando GT Jr, Ostroff SM. Transmission of multidrug-resistant Mycobacterium tuberculosis among persons exposed in a medical examiner's office, New York. Infect Control Hosp Epidemiol 1995;16:160–165.
399.Hutton MD, Stead WW, Cauthen GM, Bloch AB, Ewing WM. Nosocomial transmission of tuberculosis associated with a draining abscess. J Infect Dis 1990;161:286–295.
400.Kramer F, Sasse SA, Simms JC, Leedom JM. Primary cutaneous tuberculosis after a needlestick injury from a patient with AIDS and undiagnosed tuberculosis. Ann Intern Med 1993;119:594–595.
401.Rattner SL, Fleischer JA, Davidson BL. Tuberculin positivity and patient contact in healthcare workers in the urban United States. Infect Control Hosp Epidemiol 1996;17:369–371.
402.Chaisson R, Benson C. Tuberculosis. New York, NY: McGraw-Hill; 1995.
403.Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;320:545–550.
404.Pugliese G, Tapper ML. Tuberculosis control in health care. Infect Control Hosp Epidemiol 1996;17:819–827.
405.Maloney SA, Pearson ML, Gordon MT, DelCastillo R, Boyle JF, Jarvis WR. Efficacy of control measures in preventing nosocomial transmission of multidrug-resistant tuberculosis to patients and health care workers. Ann Intern Med 1995;122:90–95.
406.American Thoracic Society, Centers for Disease Control. Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis 1990;142:725–735.
407.Centers for Disease Control and Prevention. Screening for tuberculosis and tuberculosis infection in high-risk populations: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR 1995;44(RR-11):19–34.
408.Centers for Disease Control and Prevention. Anergy skin testing and preventive therapy for HIV-infected persons: revised recommendations. MMWR 1997;46(RR-15):1–10.
409.Centers for Disease Control. Management of persons exposed to multidrug-resistant tuberculosis. MMWR 1992;41(RR-11):59–71.
410.Rodrigues L, Diwan D, Wheeler J. Protective effect of BCG against tuberculosis meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 1993;22:1154–1158.
411.Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, et al.Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA 1994;271:698–702.
412.Centers for Disease Control and Prevention. The role of BCG vaccine in the prevention and control of tuberculosis in the United States: a joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. MMWR 1996;45(RR-4):1–18.
413.Lotte A, Wasz-Hockert O, Poisson N, Engbaek H, Landmann H, Quast U. Second IUATLD study on complications induced by intradermal BCG vaccination. Bull Int Union Tuberc Lung Dis 1988;63:47–59.
414.Caglayan S, Yegin O, Kayran K, Timocin N, Kasirga E, Gun M. Is medical therapy effective for regional lymphadenitis following BCG vaccination? Am J Dis Child 1987;141:1213–1214.
415.Brewer T, Colditz G. Bacille Calmette-Guérin vaccination for prevention of tuberculosis in health care workers. Clin Infect Dis 1995; 20:136–142.
416.Centers for Disease Control. Disseminated Mycobacterium bovis infection from BCG vaccination of a patient with acquired immunodeficiency syndrome. MMWR 1985;34:227–228.
417.Ninane J, Grymonprez A, Burtonboy G, Francois A, Cornu G. Disseminated BCG in HIV infection. Arch Dis Child 1988;63:1268–1269.
418.Smith E, Thybo S, Bennedsen J. Infection with Mycobacterium bovis in a patient with AIDS: a late complication of BCG vaccination. Scand J Infect Dis 1992;24:109–110.
419.von Reyn CF, Clements CJ, Mann JM. Human immunodeficiency virus infection and routine childhood immunisation. Lancet 1987;2:669–672.
420.Comstock GW, Edwards LB, Nabangxang H. Tuberculin sensitivity eight to fifteen years after BCG vaccination. Am Rev Respir Dis 1971;103:572–575.
421.Guld J, Waaler H, Sundaresan TK, Kaufmann PC, Dam HG. The duration of BCG-induced tuberculin sensitivity in children, and its irrelevance for revaccination: results of two 5-year prospective studies. Bull World Health Organ 1968;39:829–836.
422.Orefici G, Scopetti F, Grandolfo ME, Annes I, Kissopoulos A. Study of a BCG vaccine: influence of dose and time. Boll Ist Sieroter Milan 1982;61:24–28.
423.Fine PEM, Pönnighaus JM, Maine NP. The relationship between delayed type hypersensitivity and protective immunity induced by mycobacterial vaccines in man. Lepr Rev 1986;57(suppl 2):275–283.
424.Fine PEM, Sterne JAC, Pönnighaus JM, Rees RJW. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet 1994;344:1245–1249.
425.American Thoracic Society, Centers for Disease Control. The tuberculin test. Am Rev Respir Dis 1981;124:356–363.
426.Lane JM, Ruben FL, Neff JM, Millar JD. Complications of smallpox vaccination, 1968: results of ten statewide surveys. J Infect Dis 1970;122:303–309.
427.Centers for Disease Control. Contact spread of vaccinia from a recently vaccinated Marine—Louisiana. MMWR 1984;33:37–38.
428.Centers for Disease Control. Contact spread of vaccinia from a National Guard vaccinee—Wisconsin. MMWR 1985;34:182–183.
429.Centers for Disease Control. Vaccinia outbreak—Newfoundland. MMWR 1981;30:453–455.
430.Meyers JD, MacQuarrie MB, Merigan TC, Jennison MH. Nosocomial varicella. Part 1: outbreak in oncology patients at a children's hospital. West J Med 1979;130:196–199.
431.Morens DM, Bregman DJ, West CM, Green MH, Mazur MH, Dolin R, et al.An outbreak of varicella-zoster virus infection among cancer patients. Ann Intern Med 1980;93:414–419.
432.Baltimore RS. Nosocomial infections in the pediatric intensive care unit. Yale J Biol Med 1984;57:185–197.
433.Gustafson TL, Shebab A, Brunell PA. Outbreak of varicella in a newborn intensive care nursery. Am J Dis Child 1984;138:548–550.
434.Hyams PJ, Stuewe MCS, Heitzer V. Herpes zoster causing varicella (chicken pox) in hospital employees: cost of a casual attitude. Infect Control 1984;12:2–5.
435.Weitekamp MR, Schan P, Aber RC. An algorithm for the control of varicella-zoster virus infection. Am J Infect Control 1985;13:193–198.
436.Alter SJ, Hammond JA, McVey CJ, Myers MG. Susceptibility to varicella-zoster virus among adults at high risk for exposure. Infect Control 1986;7:448–451.
437.Krasinski K, Holzman RS, LaCouture R, Florman A. Hospital experience with varicella-zoster virus. Infect Control 1986;7:312–316.
438.Haiduven-Griffiths D, Fecko H. Varicella in hospital personnel: a challenge for the infection control practitioner. Am J Infect Control 1987;15:207–211.
439.Weber DJ, Rutala WA, Parham C. Impact and costs of varicella prevention in a university hospital. Am J Public Health 1988;78:19–23.
440.McKinney WP, Horowitz MM, Battiola RJ. Susceptibility of hospitalbased health care personnel to varicella-zoster virus infections. Am J Infect Control 1989;17:26–30.
441.Weber DJ, Rutala WA, Hamilton H. Prevention and control of varicella-zoster infections in healthcare facilities. Infect Control Hosp Epidemiol 1996;17:694–705.
442.American Academy of Pediatrics. Summaries of infectious diseases: varicella-zoster infections. In: Peter G, ed. 1997 Red Book: Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997:573–585.
443.Asano Y, Iwayama S, Miyata T, Yazaki T, Ozaki T, Tsuzuki K, et al.Spread of varicella in hospitalized children having no direct contact with an indicator zoster case and its prevention by a live vaccine. Biken J 1980;23:157–161.
444.Sawyer MH, Chamberlin CJ, Wu YN, Aintablian N, Wallace MR. Detection of varicella-zoster virus DNA in air samples from hospital rooms. J Infect Dis 1994;169:91–94.
445.LeClair JM, Zaia JA, Levin MJ, Congdon RG, Goldmann DA. Airborne transmission of chickenpox in a hospital. N Engl J Med 1980;302:450–453.
446.Gustafson TL, Lavely GB, Brawner ER Jr, Hutcheson RH, Wright PF, Schaffner W. An outbreak of airborne nosocomial varicella. Pediatrics 1982;70:550–556.
447.Josephson A, Gombert M. Airborne transmission of nosocomial varicella from localized zoster. J Infect Dis 1988;158:238–241.
448.Ferson MJ, Bell SM, Robertson PW. Determination and importance of varicella immune status of nursing staff in a children's hospital. J Hosp Infect 1990;15:347–351.
449.Kelley PW, Petruccelli BP, Stehr-Green P, Erickson RL, Mason CJ. The susceptibility of young adult Americans to vaccine-preventable infections: a national survey of US Army recruits. JAMA 1991;266:2724–2729.
450.Struewing JP, Hyams KC, Tueller JE, Gray GC. The risk of measles, mumps, and varicella among young adults: a serosurvey of US Navy and Marine Corps recruits. Am J Public Health 1993;83:1717–1720.
451.Gershon AA, Steinberg SP, LaRussa P, Ferrara A, Hammerschlag M, Gelb L. Immunization of healthy adults with live attenuated varicella vaccine. J Infect Dis 1988;158:132–137.
452.Gardner P, Eickhoff T, Poland GA, Gross P, Griffin M, LaForce F, et al.Adult immunizations: recommendations of the American College of Physicians. Ann Intern Med 1996;124:35–40.
453.White CJ, Kuter BJ, Ngai A, Hildebrand CS, Isganitis KL, Patterson CM, et al.Modified cases of chicken pox after varicella vaccination: correlation of protection with antibody response. Pediatr Infect Dis J 1992;11:19–23.
454.Bernstein HH, Rothstein EP, Watson BM, Reisinger KS, Blatter MM, Wellman CO, et al.Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine. Pediatrics 1993;92:833–837.
455.Weibel RE, Neff BJ, Kuter BJ, Guess HA, Rothenberger CA, Fitzgerald AJ, et al.Live attenuated varicella vaccine: efficacy trial in healthy children. N Engl J Med 1984;310:1409–1415.
456.Tsolia M, Gershon AA, Steinberg SP, National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group. Live attenuated varicella vaccine: evidence that the vaccine virus is attenuated and the importance of skin lesions is transmission of varicella-zoster virus. J Pediatr 1990;116:184–189.
457.Centers for Disease Control and Prevention. Varicella-related deaths among adults—United States, 1997. MMWR 1997;46:409–412.
458.Wallace MR, Bowler WA, Murray NB, Brodine SK, Oldfield ECI. Treatment of adult varicella with oral acyclovir: a randomized, placebo-controlled trial. Ann Intern Med 1992;117:358–363.
459.Centers for Disease Control and Prevention, Hospital Infection Control Practices Advisory Committee. Guideline for prevention of nosocomial pneumonia. Infect Control Hosp Epidemiol 1994;15:587–627.
460.Balkovic ES, Goodman RA, Rose FB, Borel CO. Nosocomial influenza A (H1N1) infection. Am J Med Tech 1980;46:318–320.
461.Evans ME, Hall KL, Berry SE. Influenza control in acute care hospitals. Am J Infect Control 1997;25:357–362.
462.Kapila R, Lintz DI, Tecson FT, Ziskin L, Louria DB. A nosocomial outbreak of influenza A. Chest 1977;71:576–579.
463.Kimball AM, Foy HM, Cooney MK, Allan ID, Matlock M, Plourde JJ. Isolation of respiratory syncytial and influenza viruses from the sputum of patients hospitalized with pneumonia. J Infect Dis 1983; 147:181–184.
464.Van Voris LP, Belshe RB, Shaffer JL. Nosocomial influenza B virus infection in the elderly. Ann Intern Med 1982;96:153–158.
465.Pachucki CT, Walsh Pappas SA, Fuller GF, Krause SL, Lentino JR, Schaoff DM. Influenza A among hospital personnel and patients: implications for recognition, prevention, and control. Arch Intern Med 1989;149:77–80.
466.Centers for Disease Control. Suspected nosocomial influenza cases in an intensive care unit. MMWR 1988;37:3–4, 9.
467.Hammond GW, Cheang M. Absenteeism among hospital staff during an influenza epidemic: implications for immunoprophylaxis. Can Med Assoc J 1984;131:449–452.
468.Horman JT, Stetler HC, Israel E, Sorley O, Schiper MT, Joseph JM. An outbreak of influenza A in a nursing home. Am J Public Health 1986;76:501–504.
469.Patriarca PA, Weber JA, Parker RA, Orenstein WA, Hall WN, Kendal AP, et al.Risk factors for outbreaks of influenza in nursing homes: a case-control study. Am J Epidemiol 1986;124:114–119.
470.Centers for Disease Control. Outbreak of influenza A in a nursing home—New York, December 1991-January 1992. MMWR 1992;41:129–131.
471.Gross PA, Rodstein M, LaMontagne JR, Kaslow RA, Saah AJ, Wallenstein S, et al.Epidemiology of acute respiratory illness during an influenza outbreak in a nursing home. Arch Intern Med 1988;148:559–561.
472.Cartter ML, Renzullo PO, Helgerson SD, Martin SM, Jekel JF. Influenza outbreaks in nursing homes: how effective is influenza vaccine in the institutionalized elderly? Infect Control Hosp Epidemiol 1990;11:473–478.
473.Bean B, Moore BM, Sterner B, Peterson LR, Gerding DN, Balfour HH Jr. Survival of influenza viruses on environmental surfaces. J Infect Dis 1982;146:47–51.
474.Kilbourne ED, ed. Influenza. New York, NY: Plenum Medical Book; 1987.
475.Hall CB, Douglas RG. Nosocomial influenza infection as a cause of intercurrent fevers in infants. Pediatrics 1975;55:673–677.
476.Noble GR. Epidemiological and clinical aspects of influenza. In: Beare AS, ed. Applied Influenza Research. Boca Raton, FL: CRC Press; 1982:11–49.
477.Adal KA, Flowers RH, Anglim AM, Hayden FG, Titus MG, Coyner BJ, et al.Prevention of nosocomial influenza. Infect Control Hosp Epidemiol 1996;17:641–648.
478.Nichol KL, Margolis KL, Lind A, Murdoch M, McFadden R, Hauge M, et al.Side effects associated with influenza vaccination in healthy working adults: a randomized, placebo-controlled trial. Arch Intern Med 1996;156:1546–1550.
479.Arden NH, Patriarca PA, Fasano MB, Lui KJ, Harmon MW, Kendal AP, et al.The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home. Arch Intern Med 1988;148:865–868.
480.Falsey AR, Cunningham CK, Barker WH, Kouides RW, Yeun JB, Menegus M, et al.Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J Infect Dis 1995;172:389–394.
481.Valenti WM, Clarke TA, Hall CB, Menegus MA, Shapiro DL. Concurrent outbreaks of rhinovirus and respiratory syncytial virus in an intensive care nursery: epidemiology and associated risk factors. J Pediatr 1982;100:722–726.
482.Hall CB. Respiratory syncytial virus: its transmission in the hospital environment. Yale J Biol Med 1982;55:219–223.
483.Snydman DR, Greer C, Meissner HC, McIntosh K. Prevention of nosocomial transmission of respiratory syncytial virus in a newborn nursery. Infect Control Hosp Epidemiol 1988;9:105–108.
484.Harrington RD, Hooton TM, Hackman RC, Storch GA, Osborne B, Gleaves CA, et al.An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis 1992;165:987–993.
485.Guidry GG, Black-Payne CA, Payne DK, Jamison RM, George RB, Bocchini JA Jr. Respiratory syncytial virus infection among intubated adults in a university medical intensive care unit. Chest 1991;100:1377–1384.
486.Falsey AR. Noninfluenza respiratory virus infection in long-term care facilities. Infect Control Hosp Epidemiol 1991;12:602–608.
487.Sorvillo FJ, Huie SF, Strassburg MA, Butsumyo A, Shandera WX, Fannin SL. An outbreak of respiratory syncytial virus pneumonia in a nursing home for the elderly. J Infect 1984;9:252–256.
488.Valenti WM, Hruska JF, Menegus MA, Freeburn MJ. Nosocomial viral infections, III: guidelines for prevention and control of exanthe-matous viruses, gastroenteritis viruses, picornaviruses, and uncommonly seen viruses. Infect Control 1980;2:38–49.
489.Siegel JD. Risks and exposures for the pregnant health-care worker. In: Olmstead RN, ed. APIC Infection Control and Applied Epidemiology: Principles and Practice. St Louis, MO: Mosby; 1996:22-1, 22–28.
490.Valenti WM. Infection control and the pregnant health care worker. Nurs Clin North Am 1993;28:673–686.
491.Shortridge-McCauley LA. Reproductive hazards: an overview of exposures to health care workers. AAOHN J 1995;43:614–621.
492.Pike RM. Past and present hazards of working with infectious agents. Arch Pathol Lab Med 1978;102:333–336.
493.Pike RM. Laboratory-associated infections: incidence, fatalities, causes, and prevention. Annu Rev Microbiol 1979;33:41–66.
494.Favero MS. Biological hazards in the laboratory. Lab Med 1987;18:665–670.
495.Jacobson JT, Orlob RB, Clayton JL. Infections acquired in clinical laboratories in Utah. J Clin Microbiol 1985;21:486–489.
496.Grist NR, Emslie JAN. Infections in British clinical laboratories, 198687. J Clin Pathol 1989;42:677–681.
497.Vesley D, Hartmann HM. Laboratory-acquired infections and injuries in clinical laboratories: a 1986 survey. Am J Public Health 1988; 78:1213–1215.
498.Grist NR, Emslie JAN. Association of Clinical Pathologists' survey of infection in British clinical laboratories, 1970-1989. J Clin Pathol 1994;47:391–394.
499.Gilchrist MJR, Hindler J, Fleming DO. Laboratory safety management. In: Isenberg HI, ed. Clinical Microbiology Procedures Handbook. Washington, DC: American Society for Microbiology; 1992:xxix–xxxvii.
500.Gilchrist MJR. Biosafety precautions for airborne pathogens. In: Fleming DO, Richardson JH, Tulis JJ, Vesley D, eds. Laboratory Safety Principles and Practices. 2nd ed. Washington, DC: American Society for Microbiology; 1995:67–76.
501.Centers for Disease Control and Prevention. Implementation of provisions of the Ryan White Comprehensive AIDS Resources Emergency Act regarding emergency response employees. Federal Register 1994;59(54):13418–13428.
502.Hamann CP. Natural rubber latex protein sensitivity in review. Contact Dermatitis 1993;4:4–21.
503.Zaza S, Reeder JM, Charles LE, Jarvis WR. Latex sensitivity among perioperative nurses. AORN J 1994;60:806–812.
504.Bubak ME, Reed CE, Fransway AF, Yunginger JW, Jones RT, Carlson CA, et al.Allergic reactions to latex among health-care workers. Mayo Clin Proc 1992;67:1075–1079.
505.Berky ZT, Luciano WJ, James WD. Latex glove allergy: a survey of the US Army Dental Corps. JAMA 1992;268:2695–2697.
506.Yassin MS, Lierl MB, Fischer TJ, O'Brian K, Cross J, Steinmetz C. Latex allergy in hospital employees. Ann Allergy 1994;72:245–249.
507.Fisher AA. Allergic contact reactions in health personnel. J Allergy Clin Immunol 1992;90:729–738.
508.Hunt LW, Fransway AF, Reed CE, Miller LK, Jones RT, Swanson MC, et al.An epidemic of occupational allergy to latex involving health care workers. J Occup Environ Med 1995;37:1204–1209.
509.Sussman GL, Tario S, Dolovich J. The spectrum of IgE-mediated responses to latex. JAMA 1991;265:2844–2847.
510.Cormio L, Turjanmaa K, Talja M, Anderson LC, Ruutu M. Toxicity and immediate allergenicity of latex gloves. Clin Exp Allergy 1993;23:618–623.
511.Hamann CP, Kick SA. Update: immediate and delayed hypersensitivity to natural rubber latex. Cutis 1993;52:307–311.
512.Ownby DR. Manifestation of latex allergy. Immun Allergy Clin North Am 1995;15:31–43.
513.Estlander T, Jolanski R, Kanerva L. Dermatitis and urticaria from rubber and plastic gloves. Contact Dermatitis 1985;14:20–25.
514.Conde-Salazar L, del-Rio E, Guimaraens D, Gonzalez DA. Type IV allergy to rubber additives: a 10-year study of 686 cases. J Am Acad Dermatol 1993;29:176–180.
515.Heese A, Hintzenstern J, Peters KP, Koch HU, Hornstein OP. Allergic and irritant reactions to rubber gloves in medical health services. J Am Acad Dermatol 1991;25:831–839.
516.Lagier F, Vervloet D, Lhermet I, Poyen D, Charpin D. Prevalence of latex allergy in operating room nurses. J Allergy Clin Immunol 1992;90:319–322.
517.Gerber AC, Jorg W, Zbinden S, Seger RA, Dangel PH. Severe intraoperative anaphylaxis to surgical gloves: latex allergy, an unfamiliar condition. Anesthesiology 1989;71:800–802.
518.Arellano R, Bradley J, Sussman G. Prevalence of latex sensitization among hospital physicians occupationally exposed to latex gloves. Anesthesiology 1992;77:905–908.
519.Kaczmarek RG, Silverman BG, Gross TP, Hamilton RG, Kessler E, Arrowsmith-Lowe JT, et al.Prevalence of latex-specific IgE antibodies in hospital personnel. Ann Allergy Asthma Immunol 1996;76:51–56.
520.Marcos C, Lazaro M, Fraj J, Quirce S, de la Hoz B, Fernandes-Rivas M, et al.Occupational asthma due to latex surgical gloves. Ann Allergy 1991;67:319–323.
521.Frosch PJ, Wahl R, Bahmer FA, Maasch HJ. Contact urticaria to rubber gloves is IgE-mediated. Contact Dermatitis 1986;14:241–245.
522.Vandenplas O, Delwiche JP, Evrard G, Aimont P, VanDerBrempt X, Jamart J, et al.Prevalence of occupational asthma due to latex among hospital personnel. Am J Respir Crit Care Med 1995;151:54–60.
523.Tarlo SM, Wong L, Roos J, Booth N. Occupational asthma caused by latex in a surgical glove manufacturing plant. J Allergy Clin Immunol 1990;85:626–631.
524.Seaton A, Cherrie B, Turnbull J. Rubber glove asthma. BMJ 1988;296:531–532.
525.O'Byrne PM, Dolovich J, Hargreave FE. Late asthmatic responses. Am Rev Respir Dis 1987;136:130–131.
526.De Zotti R, Larese F, Fiorito A. Asthma and contact urticaria from latex gloves in a hospital nurse. Br J Ind Med 1992;49:596–598.
527.Brugnami G, Marabini A, Siracusa A, Abbritti G. Work-related late asthmatic response induced by latex allergy. J Allergy Clin Immunol 1995;96:457–464.
528.Alenius H, Makinen-Kiljunes S, Turjanmaa K, Palosuo T, Reunala T. Allergen and protein content of latex gloves. Ann Allergy 1994;73:315–320.
529.Yunginger JW, Jones RT, Fransway AF, Kelso JM, Warner MA, Hunt LW. Extractable latex allergens and proteins in disposable medical gloves and other rubber products. J Allergy Clin Immunol 1994; 93:836–842.
530.Food and Drug Administration. Latex-containing devices; user labeling. Federal Register 1996;61:32617–32621.
531.Jaeger D, Kleinhans D, Czuppon AB, Baur X. Latex-specific proteins causing immediate-type cutaneous, nasal, bronchial, and systemic reactions. J Allergy Clin Immunol 1992;89:759–768.
532.Grzybowski M, Ownby DR, Peyser PA, Johnson CC, Schork MA. The prevalence of anti-latex IgE antibodies among registered nurses. J Allergy Clin Immunol 1996;98:535–544.
533.Turjanmaa K. Incidence of immediate allergy to latex gloves in hospital personnel. Contact Dermatitis 1987;17:270–275.
534.Swanson MC, Bubak ME, Hunt LW, Yunginger JW, Warner MA, Reed LE. Quantification of occupational latex aeroallergens in a medical center. J Allergy Clin Immunol 1994;94:445–451.
535.Shield SW, Blaiss MS. Prevalence of latex sensitivity in children evaluated for inhalant allergy. Allergy Proc 1992;13:129–131.
536.M'Raihi L, Cahrpin D, Pons A, Bongrand P, Vervloet D. Cross-reactivity between latex and banana. J Allergy Clin Immunol 1991;87:129–130.
537.Kurup VJ, Kelly T, Elms N, Kelly K, Fink J. Cross-reactivity of food allergens in latex allergy. Allergy Proc 1994;15:211–216.
538.Blanco C, Carrillo T, Castillo R, Quiralte J, Cuevas M. Avocado hypersensitivity. Allergy 1994;49:454–459.
539.Ahlroth M, Alenius H, Turjanmaa K, Mäkinen-Kiljunen S, Reunala T, Palosuo T. Cross-reacting allergens in natural rubber latex and avocado. J Allergy Clin Immunol 1995;96:167–173.
540.Fernandez de Corres L, Moneo I, Munoz D, Bernaloa G, Fernandez E, Audicana M, et al.Sensitization from chestnuts and bananas in patients with urticaria and anaphylaxis from contact with latex. Ann Allergy 1993;70:35–39.
541.Kelly KJ, Kurup V, Zacharisen M, Resnick A, Fink JN. Skin and sero-logic testing in the diagnosis of latex allergy. J Allergy Clin Immunol 1993;91:1140–1145.
542.Equal Employment Opportunity Commission. Equal employment opportunity for individuals with disabilities. 29 CFR 1630. Federal Register 1991;56:35726–35753.
543.Bureau of National Affairs. Title VII jurisdiction: Equal Opportunity Commission compliance manual. Washington, DC: Bureau of National Affairs; 1986:147–149.
544.Department of Justice. Title II technical assistance manual: the Americans with Disabilities Act. Washington, DC: Department of Justice; 1993:1–12.
545.Department of Justice. Title III technical assistance manual: the Americans with Disabilities Act. Washington, DC: Department of Justice; 1993:2–14.
546.Korniewicz DM, Kirwin M, Larson E. Do your gloves fit the task? Am J Nurs 1991;91:38–40.
547.Korniewicz DM. Effectiveness of glove barriers used in clinical settings. Medsurg Nurs 1992;1:29–32.
548.Korniewicz DM, Laughon BE, Butz A, Larson E. Integrity of vinyl and latex procedure gloves. Nurs Res 1989;38:144–146.
549.Korniewicz DM. Barrier protection of latex. Immun Allergy Clin North Am 1995;15:123–127.